Results 1 to 10 of about 384,691 (193)

Emerging Therapies for Hepatocellular Carcinoma (HCC)

Cancers, 2022
Simple Summary Primary liver cancer, also known as Hepatocellular carcinoma (HCC), is considered to be a major global health challenge. Due to delays in diagnosis at early asymptomatic stages, HCC reaches a severe aggressive stage, thereby having a ...
Eesha Chakraborty, D. Sarkar
semanticscholar   +3 more sources

Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overview [PDF]

Journal of the Egyptian National Cancer Institute, 2020
Worldwide, hepatocellular carcinoma (HCC) is a universal problem and its epidemiological data showed variation from place to place. Hepatocellular carcinoma (HCC) is the sixth and fourth common cancer in worldwide and Egypt, respectively. Egypt ranks the
W. Rashed, M. Kandeil, M. O. Mahmoud, S. Ezzat   +3 more
semanticscholar   +4 more sources

Hepatocellular carcinoma (HCC): a global perspective.

Journal of Clinical Gastroenterology, 2010
Peter Ferenci (chair) (Austria) Michael Fried (Switzerland) Douglas Labrecque (USA) J. Bruix (Spain) M. Sherman (Canada) M. Omata (Japan) J. Heathcote (Canada) T. Piratsivuth (Thailand) Mike Kew (South Africa) Jesse A. Otegbayo (Nigeria) S.S. Zheng (China) S. Sarin (India) S.
P. Ferenci, M. Fried, D. Labrecque, J. Bruix, M. Sherman, M. Omata, J. Heathcote, T. Piratsivuth, M. Kew, J. Otegbayo, Shu Zheng, S. Sarin, S. Hamid, S. B. Modawi, W. Fleig, S. Fedail, A. Thomson, A. Khan, P. Malfertheiner, G. Lau, F. Carillo, J. Krabshuis, A. Le Mair   +22 more
semanticscholar   +3 more sources

Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression

International Journal of Molecular Sciences, 2023
According to the WHO’s recently released worldwide cancer data for 2020, liver cancer ranks sixth in morbidity and third in mortality among all malignancies. Hepatocellular carcinoma (HCC), the most common kind of liver cancer, accounts approximately for
Maria Kotsari, Vassiliki Dimopoulou, J. Koskinas, A. Armakolas   +3 more
semanticscholar   +4 more sources

Gene Signatures in Hepatocellular Carcinoma (HCC) [PDF]

Seminars in Cancer Biology, 2010
Primary hepatocellular carcinoma (HCC) is a significant human cancer globally, with poor prognosis. New and efficacious therapy strategies are needed as well as new biomarkers for early detection of at-risk patients.
O. Andrisani, Leo L. Studach, P. Merle
semanticscholar   +4 more sources

MRI in detection of hepatocellular carcinoma (HCC) [PDF]

Cancer Imaging, 2005
Hepatocellular carcinoma (HCC) is the commonest malignancy of the liver and is usually due to cirrhosis. Early detection of HCC and the premalignant dysplastic nodules has implications on the management options of tumor ablation, liver resection and ...
S. Digumarthy, D. Sahani, S. Saini
semanticscholar   +3 more sources

Hepatocellular carcinoma (HCC): beyond sorafenib-chemotherapy. [PDF]

Journal of Gastrointestinal Oncology, 2017
Hepatocellular carcinoma (HCC) is the most common primary liver cancer with poor prognosis. The incidence of HCC and HCC-related deaths have increased over the last several decades.
D. Kim, Chetasi Talati, R. Kim
semanticscholar   +3 more sources

[Hepatocellular carcinoma (HCC)]. [PDF]

Med Trop Sante Int
Primary liver cancers are tumors that develop from different liver cells. Hepatocellular carcinoma (HCC), which develops from hepatocytes, accounts for approximately 75-85% of primary liver cancers.HCC is the 6th leading cause of cancer worldwide and the 3rd leading cause of cancer-related death. Its incidence is low in northern Europe, but high in sub-
Pol S.
europepmc   +4 more sources

Advances in Immunotherapy for Hepatocellular Carcinoma (HCC). [PDF]

Curr Oncol, 2023
Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related deaths in the world. More than half of patients with HCC present with advanced stage, and highly active systemic therapies are crucial for improving outcomes. Immune checkpoint inhibitor (ICI)-based therapies have emerged as novel therapy options for advanced HCC. Only one
Bicer F, Kure C, Ozluk AA, El-Rayes BF, Akce M.   +4 more
europepmc   +4 more sources

Hepatocellular carcinoma (HCC)

Concise Notes in Oncology for MRCP and MRCS, 2018
What is HCC? HCC is a primary liver cancer. In the United States, about 33,000 adult cases are found each year. Liver cancer is much more common in developing countries within Africa and Asia. What are the risk factors for HCC?
cTACE Vs. Deb-Tace
semanticscholar   +2 more sources